Target intelligence / Profile preview

Human chromatin

Molecular classification
Nucleoprotein complex, Epigenetic regulator, Other
01

Overview

Human chromatin is a highly organized complex of DNA and proteins, primarily histones, that packages the genome within the cell nucleus (NHGRI, 2024). It serves as the physiological template for all genetic processes, including transcription, replication, and repair, by alternating between condensed (heterochromatin) and relaxed (euchromatin) states (Nature Education, 2014). Dysregulation of chromatin structure and the epigenetic marks that govern it is a fundamental driver of various diseases, particularly cancer, where it leads to the silencing of tumor suppressor genes or the activation of oncogenes (Nature Reviews Cancer, 2016). Therapeutic strategies involve small molecules that inhibit enzymes responsible for modifying histones or DNA, as well as agents that bind directly to the DNA-protein complex to disrupt cellular proliferation (Clinical Epigenetics, 2021). Understanding chromatin dynamics is essential for developing precision medicines that can selectively reset the epigenetic landscape of diseased cells (Nature Reviews Drug Discovery, 2018).

Other names
Nucleoprotein complexChromosomal materialEuchromatinHeterochromatin
02

Mechanism of action

Drugs target chromatin through several mechanisms: epigenetic modulation via inhibition of "writers", "erasers", or "readers" (e.g., HDAC and DNMT inhibitors); direct DNA intercalation to disrupt topoisomerase activity; and covalent DNA cross-linking to prevent strand separation (Nature Reviews Drug Discovery, 2018; PubMed, 2019).

03

Biological functions

DNA packaging (NHGRI, 2024)Gene expression regulation (Nature Education, 2014)DNA replication (PubMed, 2020)DNA repair (NCBI, 2021)Chromosome segregation (Wikipedia, 2024)
04

Disease associations

Cancer (Nature Reviews Cancer, 2016)Systemic lupus erythematosus (PubMed, 2018)Neurodevelopmental disorders (Cell, 2020)Hematologic malignancies (Blood, 2019)
05

Safety considerations

MyelosuppressionOff-target epigenetic effectsCardiotoxicitySecondary malignanciesTeratogenicity
06

Interacting drugs

Vorinostat

6 more in the full profile.

07

Biomarkers

Histone H3 acetylation levelsDNA methylation patternsChromatin accessibility (ATAC-seq)Gamma-H2AX for DNA damage

Beyond the preview

Go deeper on Human chromatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human chromatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call